more" /> more" /> more" />
PSP Society of Canada
PSP Society of Canada
Email
info@pspsocietycanada.ca
Call Now
1.888.675.0230
  • Home
  • About Us
  • Donate
  • Events
  • News
  • Educational Downloads
  • Volunteering

$4 Million in Research Funding Awarded for Alzheimer’s, Frontotemporal Degeneration & other Tauopathies Such as PSP

Homepage News $4 Million in Research Funding Awarded for Alzheimer’s, Frontotemporal Degeneration & other Tauopathies Such as PSP
News

$4 Million in Research Funding Awarded for Alzheimer’s, Frontotemporal Degeneration & other Tauopathies Such as PSP

June 1, 2020
By admin
0 Comment
443 Views

Kingston — Monday June 1st, 2020 — On March 4th, 2020, The Alzheimer’s Association in partnership with the Rainwater Charitable Foundation announced $4 Million in funding aimed at supporting new drug discovery approaches seeking to mitigate the impact of abnormal tau proteins.

Tau, a key player in Alzheimer’s and other taupathies such as PSP has been shown to hold the potential to slow and potentially prevent such illnesses.

Eight successful research candidates were awarded funding out of a pool of over 100 impressive applicants. The list of recipients and the original publication announcing the awards can be accessed using the link below.

Details:

News Provided by: Rainwater Foundation
Link to publication: Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer’s And Other Dementia

The PSP Society of Canada serves patients and families dealing with Progressive Supranuclear Palsy (PSP) and related diseases such as Multiple System Atrophy (MSA) and Corticobasal Degeneration (CBD). For more information please visit. www.pspsocietycanada.ca


Previous Story
PSP Society of Canada Announces Physical Therapy Program
Next Story
PSP Society of Canada Announces Recipe Program

Related Articles

PSP Society of Canada Announces first ASK THE DIETITIAN SESSION

Organization to host Canadian Dietitian & Dysphagia Expert remotely to...

Research Validates Blood Test for Detecting Tau and Amyloid-B Pathologies

An analysis of consolidated data seeking new ways of accelerating...

Recent Post

  • PSP Society of Canada Announces first ASK THE DIETITIAN SESSION Monday, 12, Apr
  • PSP Society of Canada Announces first ASK THE NEUROLOGIST SESSION Saturday, 8, Aug
  • Research Validates Blood Test for Detecting Tau and Amyloid-B Pathologies Wednesday, 24, Jun
  • MRI Biomarkers Distinguish Progressive Supranuclear Palsy from Idiopathic Normal Pressure Hydrocephalus Tuesday, 9, Jun
  • PSP Society of Canada Announces Recipe Program Wednesday, 3, Jun

Recent Comments

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Tags

    Disease foundation michael j fox Neurodegenerative Proteins Treatment

    About Us

    The PSP Society of Canada serves patients and families dealing with Progressive Supranuclear Palsy (PSP) and related diseases such as Multiple System Atrophy (MSA) and Corticobasal Degeneration (CBD).

     

    Click here to read about our framework for ethical collaboration with researchers, healthcare professionals & pharmaceutical companies.

    Contact Info

    Contact Us

    PO Box 40, Station Main
    Kingston, ON K7L 4V6

    1-888-675-0230

    info@pspsocietycanada.ca

    News

    • PSP Society of Canada Announces first ASK THE DIETITIAN SESSION Monday, 12, Apr
    • PSP Society of Canada Announces first ASK THE NEUROLOGIST SESSION Saturday, 8, Aug
    • Research Validates Blood Test for Detecting Tau and Amyloid-B Pathologies Wednesday, 24, Jun

    Follow Us

    Follow Us on FacebookFollow Us on InstagramFollow Us on TwitterFollow Us on YouTube

     

     

    Programs

    Support Groups                      (REGISTER HERE)

    Annual Remembrances

    Physical Therapy for PSP

    PSP Recipe Program

    Educational Material

    Copyright ©2017 PSP Society of Canada. All Rights Reserved
    • Home
    • About Us
    • Donate
    • Events
    • Latest News
    • Educational Downloads
    • Volunteering
    Search